---
$id: https://graph.org.ai/products/commodity/51334407
$type: Product
source: UNSPSC
code: "51334407"
title: "Fenimide"
class: "51334400"
classTitle: "Antipsychotics, synthesized"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fenimide

**UNSPSC Code**: 51334407
**Class**: [Antipsychotics, synthesized](Antipsychotics, synthesized.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent with the molecular formula C13H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5Z48G09KOD, chemically known as 2,5-pyrrolidinedione, 4-ethyl-3-methyl-3-phenyl- but generally known as fenimide, which bears US NIH Compound Identifier 6068. European Medicines Agency schedules Fenimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07565MIG. The term FENIMIDE is an International Non-Proprietary Name. FENIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenimide under HS 29251995 and SITC 51482. As of Q4 2014, FENIMIDE remains the US FDA Preferred Term for this commodity. Fenimide bears US NLM identifiers UMLS ID C2825693 and NCI Concept Code C81583. SMILES: O=C1NC(=O)C(C1(C1CCCCC1)C)CC.

